Emerging role of an immunomodulatory protein secretoglobin 3A2 in human diseases

Shioko Kimura, Shigetoshi Yokoyama, Aprile L. Pilon, Reiko Kurotani

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Secretoglobin (SCGB) 3A2 was first identified in 2001 as a protein exhibiting similarities in amino acid sequence and gene structure to SCGB1A1, a multi-functional cytokine-like molecule highly expressed in airway epithelial Club cells that was the first identified and extensively studied member of the SCGB gene superfamily. SCGB3A2 is a small secretory protein of ~10 kDa that forms a dimer and a tetramer. SCGB3A2 is predominantly expressed in airway epithelial Club cells, and has anti-inflammatory, growth factor, anti-fibrotic, and anti-cancer activities that influence various lung diseases. This review summarizes the current understanding of SCGB3A2 biological functions and its role in human diseases with emphasis on its mechanisms of actions and signaling pathway.

Original languageEnglish (US)
Article number108112
JournalPharmacology and Therapeutics
StatePublished - Aug 2022

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Emerging role of an immunomodulatory protein secretoglobin 3A2 in human diseases'. Together they form a unique fingerprint.

Cite this